Sanofi
SNY
SNY
700 hedge funds and large institutions have $12.7B invested in Sanofi in 2023 Q4 according to their latest regulatory filings, with 96 funds opening new positions, 196 increasing their positions, 288 reducing their positions, and 74 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
6% less capital invested
Capital invested by funds: $13.5B → $12.7B (-$813M)
27% less funds holding in top 10
Funds holding in top 10: 11 → 8 (-3)
32% less repeat investments, than reductions
Existing positions increased: 196 | Existing positions reduced: 288
Holders
700
Holding in Top 10
8
Calls
$97.5M
Puts
$89.6M
Top Buyers
| 1 | +$418M | |
| 2 | +$77.9M | |
| 3 | +$51.5M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$38.1M |
| 5 |
MIS
Morningstar Investment Services
Chicago,
Illinois
|
+$36.6M |
Top Sellers
| 1 | -$148M | |
| 2 | -$120M | |
| 3 | -$65.5M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$37.6M |
| 5 |
Capital World Investors
Los Angeles,
California
|
-$33.6M |